The SENIORS trial sub-analysis showed a trend towards a beneficial effect of nebivolol on HF outcomes in patients with LVEF >35% ( 12 ).
← all excerpts
The effect of sustained-release CARvedilol in patients with hypErtension and heart failure with preserved ejection fraction: a study protocol for a pilot randomized controlled trial (CARE-preserved HF).
1
—
—